Back to News
Market Impact: 0.25
Biotech Gainers: PPCB And CELU Lead Rally On Company-Specific Catalysts
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsTechnology & InnovationCorporate EarningsAnalyst Insights
Biotech/healthcare top gainers were lifted by positive early signals: Propanc Biopharma advanced after strong preclinical pancreatic cancer data, and VolitionRx rose on positive validation of its Nu.Q NETs biomarker. Nutanix also gained on higher quarterly revenue and profit, adding to the generally constructive tone across the group.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
NTNX0.35
PPCB0.55
More News
- Musk says Terrafab chip factory could outperform rivals despite challenges
- Stocks saw new highs and big declines: How the volatile AI trade moved last week's market
- Will Warner Bros. kill Skydance — or will David Ellison kill Warner Bros?
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- How U.S. know-how is fracking Australia into a gas boom, from Texas oilmen to Trump’s energy secretary
- Cerebras Is About as Big as Nvidia's Data Center Business Was Nearly a Decade Ago. The Similarities Mostly End There.